NASDAQ:JYNT Joint (JYNT) Stock Price, News & Analysis → The only AI company you should be looking at (From Behind the Markets) (Ad) Free JYNT Stock Alerts $12.29 -0.46 (-3.61%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$12.08▼$12.7150-Day Range$9.00▼$13.0852-Week Range$7.31▼$17.68Volume76,143 shsAverage Volume139,304 shsMarket Capitalization$181.65 millionP/E RatioN/ADividend YieldN/APrice Target$21.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Joint alerts: Email Address Joint MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside74.9% Upside$21.50 Price TargetShort InterestBearish6.42% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.62Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth284.62%From $0.13 to $0.50 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.81 out of 5 starsMedical Sector407th out of 946 stocksPatent Owners & Lessors Industry3rd out of 8 stocks 3.2 Analyst's Opinion Consensus RatingJoint has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $21.50, Joint has a forecasted upside of 74.9% from its current price of $12.29.Amount of Analyst CoverageJoint has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.42% of the outstanding shares of Joint have been sold short.Short Interest Ratio / Days to CoverJoint has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in Joint has recently decreased by 2.90%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for JYNT. Previous Next 3.1 News and Social Media Coverage News SentimentJoint has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Joint this week, compared to 1 article on an average week.Search Interest2 people have searched for JYNT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Joint to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Joint insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.00% of the stock of Joint is held by insiders.Percentage Held by Institutions87.61% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Joint are expected to grow by 284.62% in the coming year, from $0.13 to $0.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is -18.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is -18.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJoint has a P/B Ratio of 7.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsThe ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. About Joint Stock (NASDAQ:JYNT)The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.Read More JYNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JYNT Stock News HeadlinesMarch 18, 2024 | americanbankingnews.comCritical Review: Joint (NASDAQ:JYNT) versus CareRx (OTCMKTS:CHHHF)March 12, 2024 | markets.businessinsider.comOn Holding Posts Adj. Loss In Q4 - Quick FactsMarch 19, 2024 | Porter & Company (Ad)Urgent new message from Porter StansberryI’ve been in the financial markets for close to three decades… Yet, I’ve never seen an opportunity that’s so urgent, so critical, and yet so overlooked than what is unfolding right now. You see, in one corner of the markets a financial anomaly has emerged that promises to be the single most important story of 2024.March 11, 2024 | americanbankingnews.comThe Joint Corp. (NASDAQ:JYNT) Receives $21.00 Consensus Price Target from AnalystsMarch 9, 2024 | finance.yahoo.comEarnings Miss: The Joint Corp. Missed EPS And Analysts Are Revising Their ForecastsMarch 8, 2024 | finance.yahoo.comThe Joint Corp. (NASDAQ:JYNT) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finance.yahoo.comThe Joint Corp (JYNT) Faces Net Loss in 2023 Despite Revenue GrowthMarch 8, 2024 | investorplace.comJYNT Stock Earnings: Joint Misses EPS, Beats Revenue for Q4 2023March 19, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 7, 2024 | msn.comJoint GAAP EPS of -$0.75 misses by $0.76, revenue of $30.6M beats by $1.52MMarch 7, 2024 | globenewswire.comThe Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial ResultsMarch 6, 2024 | seekingalpha.comJoint Q4 2023 Earnings PreviewMarch 4, 2024 | finance.yahoo.comThe Joint Corp. to Participate in the 36th Annual Roth ConferenceMarch 4, 2024 | globenewswire.comThe Joint Corp. to Participate in the 36th Annual Roth ConferenceMarch 2, 2024 | usatoday.comBest joint personal loans of February 2024February 22, 2024 | finance.yahoo.comThe Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 ResultsFebruary 22, 2024 | globenewswire.comThe Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 ResultsFebruary 15, 2024 | uk.investing.comThe Joint Corp (JYNT)January 24, 2024 | finance.yahoo.comThe Joint Chiropractic Named No. 1 in Chiropractic Services, Ranked Among Top Franchises in Entrepreneur Magazine's Franchise 500January 15, 2024 | finance.yahoo.comWith 51% ownership of the shares, The Joint Corp. (NASDAQ:JYNT) is heavily dominated by institutional ownersJanuary 11, 2024 | msn.comThe Joint reports growth in 2023 operating metrics below 2022 levelJanuary 11, 2024 | finance.yahoo.comThe Joint Corp. Reports 2023 Operating MetricsJanuary 7, 2024 | investopedia.comHow to Get a Joint Personal LoanJanuary 5, 2024 | fool.comBest Joint Savings Accounts for January 2024January 5, 2024 | usatoday.comBest joint checking accounts of January 2024December 29, 2023 | finance.yahoo.comReturns Are Gaining Momentum At Joint (NASDAQ:JYNT)December 13, 2023 | finance.yahoo.comJoint (NASDAQ:JYNT) investors are sitting on a loss of 63% if they invested three years agoSee More Headlines Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/13/2023Today3/19/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Patent owners & lessors Sub-IndustryN/A Current SymbolNASDAQ:JYNT CUSIPN/A CIK1612630 Webwww.thejoint.com Phone(480) 245-5960Fax480-513-7989Employees444Year FoundedN/APrice Target and Rating Average Stock Price Target$21.50 High Stock Price Target$30.00 Low Stock Price Target$13.00 Potential Upside/Downside+74.9%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.66) Trailing P/E RatioN/A Forward P/E Ratio94.54 P/E GrowthN/ANet Income$-9,750,000.00 Net Margins-8.19% Pretax Margin1.39% Return on Equity7.80% Return on Assets2.65% Debt Debt-to-Equity Ratio0.08 Current Ratio1.32 Quick Ratio1.03 Sales & Book Value Annual Sales$117.70 million Price / Sales1.54 Cash Flow$0.76 per share Price / Cash Flow16.26 Book Value$1.68 per share Price / Book7.32Miscellaneous Outstanding Shares14,780,000Free Float14,185,000Market Cap$181.65 million OptionableOptionable Beta1.57 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Peter D. Holt (Age 65)CEO, President & Director Comp: $469.55kJake Singleton (Age 42)Chief Financial Officer Comp: $280.92kMr. Jorge ArmenterosSenior Vice President of OperationsMr. Charles NellesChief Technology OfficerDr. Steven KnaufVice President of Chiropractic & ComplianceMs. Lori I. Abou Habib (Age 44)Chief Marketing Officer Ms. Krischelle TennessenChief Human Resources OfficerMr. Eric SimonSenior VP of Franchise Sales & DevelopmentMr. Craig P. Colmar J.D. (Age 71)Secretary Comp: $37kMore ExecutivesKey CompetitorsGlobal Cord BloodNYSE:COOrganigramNASDAQ:OGICapricor TherapeuticsNASDAQ:CAPRGeneluxNASDAQ:GNLXTheseus PharmaceuticalsNASDAQ:THRXView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 16,387 shares on 3/11/2024Ownership: 6.988%Sierra Summit Advisors LLCBought 67,857 shares on 2/22/2024Ownership: 0.460%Vanguard Group Inc.Sold 16,387 shares on 2/15/2024Ownership: 6.990%Citadel Advisors LLCBought 19,900 shares on 2/15/2024Ownership: 0.000%Barclays PLCBought 17,074 shares on 2/15/2024Ownership: 0.209%View All Insider TransactionsView All Institutional Transactions JYNT Stock Analysis - Frequently Asked Questions Should I buy or sell Joint stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares. View JYNT analyst ratings or view top-rated stocks. What is Joint's stock price target for 2024? 3 brokerages have issued 1 year price objectives for Joint's shares. Their JYNT share price targets range from $13.00 to $30.00. On average, they anticipate the company's stock price to reach $21.50 in the next year. This suggests a possible upside of 74.9% from the stock's current price. View analysts price targets for JYNT or view top-rated stocks among Wall Street analysts. How have JYNT shares performed in 2024? Joint's stock was trading at $9.61 on January 1st, 2024. Since then, JYNT shares have increased by 27.9% and is now trading at $12.29. View the best growth stocks for 2024 here. When is Joint's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our JYNT earnings forecast. How were Joint's earnings last quarter? The Joint Corp. (NASDAQ:JYNT) issued its earnings results on Wednesday, September, 13th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.02. The business had revenue of $29.31 million for the quarter, compared to the consensus estimate of $29.85 million. Joint had a negative net margin of 8.19% and a positive trailing twelve-month return on equity of 7.80%. What is Peter D. Holt's approval rating as Joint's CEO? 87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE). When did Joint IPO? (JYNT) raised $20 million in an initial public offering (IPO) on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager. Who are Joint's major shareholders? Joint's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (6.99%), Vanguard Group Inc. (6.99%), Skylands Capital LLC (4.09%), Dimensional Fund Advisors LP (1.21%), Northern Trust Corp (0.92%) and Russell Investments Group Ltd. (0.56%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella. View institutional ownership trends. How do I buy shares of Joint? Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:JYNT) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.